This condition had progressed more than before (Figure 2A1–8), and it was assessed to be unresectable. On November 26 and December 31, 2019, two cycles of paclitaxel 400 mg D1, cisplatin 140 mg D1, ...

Non-small-cell lung cancer (NSCLC) treatment has led to improved efficacy and compliance due to individual tailoring of the therapeutic options and the use of strategies based on both clinical ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

1 Department of Medical Oncology, Anhui University of Traditional Chinese Medicine Affiliated Liu’an Traditional Chinese Medicine Hospital, Lu’An, China 2 Department of Medical Oncology, Lu’an ...